Skip to content
← Back to this collection

PUBLICATIONS · 11986204

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2002 May 15
First author
Sawyers CL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Sawyers CL
      type
      Author
    2. name
      Hochhaus A
      type
      Author
    3. name
      Feldman E
      type
      Author
    4. name
      Goldman JM
      type
      Author
    5. name
      Miller CB
      type
      Author
    6. name
      Ottmann OG
      type
      Author
    7. name
      Schiffer CA
      type
      Author
    8. name
      Talpaz M
      type
      Author
    9. name
      Guilhot F
      type
      Author
    10. name
      Deininger MW
      type
      Author
    11. name
      Fischer T
      type
      Author
    12. name
      O'Brien SG
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Sawyers CL
      type
      Author
    2. name
      Hochhaus A
      type
      Author
    3. name
      Feldman E
      type
      Author
    4. name
      Goldman JM
      type
      Author
    5. name
      Miller CB
      type
      Author
    6. name
      Ottmann OG
      type
      Author
    7. name
      Schiffer CA
      type
      Author
    8. name
      Talpaz M
      type
      Author
    9. name
      Guilhot F
      type
      Author
    10. name
      Deininger MW
      type
      Author
    11. name
      Fischer T
      type
      Author
    12. name
      O'Brien SG
      type
      Author
    bibliography ids
    1. nci-bib-5bb72354b5672eb30252fd11
    book metadata
    content sha256
    f64fe905326abc1e256f9ed937feeca850dfe308b419b094644f4284959c471c
    document type
    citation
    dois
    1. 10.1182/blood.v99.10.3530
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11986204
    immutable id
    pubmed:11986204@f64fe905326abc1e256f9ed937feeca850dfe308b419b094644f4284959c471c
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    10
    name
    Blood
    nlm unique id
    7603509
    pages
    3530-9
    volume
    99
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11986204
      provenance
      batch id
      d4e82e28940c878dd0a2
      provider
      NCBI PubMed ESummary
      record sha256
      5f6b5400e62b3a47160d377cccca81636ab288998d034247ad359773e2e5a643
      response sha256
      257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
      retrieved at
      2026-09-09T23:45:44.017762+00:00
      publication date
      display
      2002 May 15
      precision
      day
      year
      2002
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11986204/
      title
      Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

      Preserved source evidence · Not medical advice